Patent details

EP1711528 Title: TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES

Basic Information

Publication number:
EP1711528
PCT Application Number:
PCT/US/2004/043541
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048155980
PCT Publication Number:
WO/2005/062972
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES
French Title of Invention:
TRAITEMENT DU CANCER AU MOYEN DE NOUVEAUX ANTICORPS MONOCLONAUX ANTI-IL 13
German Title of Invention:
BEHANDLUNG VON KREBS MIT NEUEN MONOKLONALEN ANTI-IL 13-ANTIKÖRPERN
SPC Number:

Dates

Filing date:
23/12/2004
Grant date:
18/07/2012
EP Publication Date:
18/07/2012
PCT Publication Date:
14/07/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/10/2006
EP B1 Publication Date:
18/07/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/12/2012
Expiration date:
23/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2004
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
MOYLE Matthew
Address:
United States (US)

2

Name:
FUNG Sek, Chung
Address:
United States (US)

Priority

Priority Number:
532130 P
Priority Date:
23/12/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages